DOI: 10.1055/s-00000133

Gastroenterologie up2date

Referenz

Kato K, Cho BC, Takahashi M. et al.
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.

Lancet Oncol 2019;
20: 1506-1517

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: